OptimizeRx up 4% on largest-ever sale

• Thinly traded micro cap OptimizeRx (OPRX +4.3%) is up in early trade, albeit on a very modest 13K shares, in reaction to its announcement that it has closed its largest-ever enterprise deal for 12 months' access to its platform and core set of solutions. It does not disclose the specific financial terms of the contract.